Navigation Links
Oncothyreon announces closing of $11.1 million registered direct financing
Date:5/27/2009

SEATTLE, May 27 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) announced today that it closed its previously announced sale of 3,878,993 shares of its common stock and warrants to purchase 2,909,244 shares of its common stock for gross proceeds of approximately $11.1 million on May 26, 2009. Oncothyreon sold the shares and warrants for $2.85 per unit (each unit consisting of one share and a warrant to purchase 0.75 shares of common stock). The exercise price of the warrants is $3.92 per share. The warrants will be exercisable at any time on or after the six-month anniversary and on or prior to the fifth anniversary of the closing of the transaction on May 26, 2009. Oncothyreon plans to use the proceeds from this financing for general corporate purposes. Boenning & Scattergood, Inc. acted as exclusive placement agent in the transaction.

A registration statement relating to these securities (File # 333-149837) has been declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor, shall there be any sale of these securities in any jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Any offer of these securities will be solely by means of a prospectus included in the registration statement and any prospectus supplement that may be issued with respect to such offering. Copies of the final prospectus, including the prospectus supplement, can be obtained at the Securities and Exchange Commission's website, www.sec.gov, from Oncothyreon at its Seattle, Washington address below or Boenning & Scattergood, Inc. by calling 1-800-883-1212.

About Oncothyreon

<
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncothyreon announces commitments to purchase $11.1 million of company securities in a registered direct financing
2. Oncothyreons PX-866 is effective in preclinical model of pulmonary fibrosis
3. Oncothyreon announces presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
4. Oncothyreon reports first quarter 2009 financial results
5. Oncothyreon regains compliance with NASDAQ listing requirements
6. Oncothyreon to present at Invest Northwest 2009
7. Oncothyreon reports full year and fourth quarter 2008 financial results
8. Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call
9. Oncothyreon to present at BIO CEO & Investor Conference 2009
10. Oncothyreon reports third quarter 2008 financial results
11. Oncothyreon to present at Rodman & Renshaw Annual Global Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Mass. , Aug. 20, 2014  Decision Resources Group finds ... , Russia , India ... $1.6 billion in 2013, roughly equal to the size of ... however, the BRIC market will experience much faster growth as a ... aging population. Other key findings from Decision Resources Group,s ...
(Date:8/20/2014)... 2014 The 6th Annual Arrowhead ... on October 29-30 in San Francisco, CA. This year’s ... government researchers and clinicians focused on addressing and solving ... In the twelve years since the sequencing of the ... introduced with pharmacogenetic information in the label and molecular ...
(Date:8/20/2014)... Aug. 20, 2014 /PRNewswire-iReach/ -- A case study ... between the school,s bioengineering department and the Intel® ... Intel® Software Academic Program, UCSD,s research focuses on ... human body.  Photo - ... the work of Dr. Todd P. Coleman ...
(Date:8/20/2014)... NJ (PRWEB) August 20, 2014 WriteResult®, ... announced today that it has expanded its myPROpad™ ePRO ... the EQ-5D-5L, one of the most widely used ... measuring general health status. The EQ-5D is used during ... generate a measure that can be used to demonstrate ...
Breaking Biology Technology:BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 36th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2EQ-5D™ Assessment Now Available for iPad 2
... AUCKLAND, New Zealand, Jan. 6 MicroDose Technologies, ... have entered into a collaboration to investigate the ... generation electronic dry powder inhaler (DPI). Under ... the development of prototypes based upon MicroDose,s inhaler ...
... leader in providing automated, molecular testing solutions, announced today ... to present at the JPMorgan Healthcare Conference, which will ... Francis Hotel in San Francisco, CA. At this conference, ... of the Company at 11:00am on Tuesday, January 13, ...
... in drug-eluting stent technologyNATICK, Mass., Jan. 6 ... today announced that it has acquired Labcoat Limited, ... located in Galway, Ireland. Terms of the ... technology for coating drug-eluting stents that uses precisely ...
Cached Biology Technology:MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler 2MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler 3Boston Scientific Acquires Labcoat Limited 2Boston Scientific Acquires Labcoat Limited 3Boston Scientific Acquires Labcoat Limited 4
(Date:8/21/2014)... A study recently published in the journal ... shows a new role for the protein adenomatous polyposis ... cause of cancer-related deaths in the U.S. , Lead ... Molecular Biosciences and co-leader of the Cancer Biology program ... part of her career trying to understand the various ...
(Date:8/21/2014)... pancreatitis involves the pancreas digesting itself resulting in severe ... the UK around 20,000 patients are diagnosed with the ... cure and treatment is restricted to intravenous fluid and ... Faculty of Life Sciences, who led the research, said ... from gall stones and excessive alcohol intake combined with ...
(Date:8/20/2014)... , Aug. 20, 2014 /CNW/ -  Issue ... and can quickly become life threatening for some children.    ... as 1.2 million Canadians have food allergies and this number ... cent of children are estimated to have food allergies.  ... mild skin irritations and hives to breathing difficulties and loss ...
Breaking Biology News(10 mins):Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3Insulin offers new hope for the treatment of acute pancreatitis 2Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3
... Network(R) Video Reports , , ... , April 27 The U.S. Supreme Court has denied the ... Richard I. Fine who has never been charged with ... in L.A. County Central Men,s jail for over a year.  Fine attempted to ...
... 2010 Dominio Amigo S.A.S , a .CO,accredited domain name registrar, ... , , ... , CEO, Dominio Amigo S.A.S , commented, "Domainmonster was a,simple choice for ... gTLD launches, securing the very best Internet real estate,for their customers." "With a ...
... NEW BERN, N.C. , April 27 A hurricane ... your business, information, because you really haven,t thought about it until now. ... Atlantic region, now,s the time to update your document storage plans so ... , , ...
Cached Biology News:U.S. Supreme Court Allows 'Coercive Confinement' to Continue in Attorney's Civil Contempt Case 2U.S. Supreme Court Allows 'Coercive Confinement' to Continue in Attorney's Civil Contempt Case 3Dominio Amigo Announce Domainmonster as .CO Technical Partner 2Dominio Amigo Announce Domainmonster as .CO Technical Partner 3Hurricane-Proof Your Information 2
...
... Certified USDA Research Registered OLAW Assured AAALAC ... AALAS Certified Technicians Documentation ... Upon Request Focus CRP is ... your custom immunology service needs. We ...
... OrientExpress™ System Modules ... synthesis and directional cloning ... T7 expression vectors ... configuring OrientExpress™ Cloning Systems, ...
...
Biology Products: